Tariff Actions Resource Page
Visit our Tariff Actions Resource Page for information, deadlines and resource documents on the various U.S. tariff actions and the responses by the rest of the world.
Trade Report Contact:
Sandler, Travis & Rosenberg Trade Report
Click here to learn more about the Sandler, Travis & Rosenberg Trade Report.
U.S. Customs and Border Protection’s Los Angeles field office issued a public bulletin Sept. 19 providing the following information on refunds of duties and fees for Food and Drug Administration-regulated goods that have been refused admission into the U.S.
The Foreign-Trade Zones Board’s annual report on FTZ activities shows that in 2015 zone activity decreased despite an increase in the number of zones.
Under section 102 of the Food Safety Modernization Act, all domestic and foreign facilities that manufacture, process, pack, or store food, food ingredients, pet foods, or dietary supplements are required to renew their registration with the FDA every even-numbered year.
The House Financial Services Committee approved by a 30-26 vote Sept. 13 a wide-ranging bill that among other things would eliminate the requirement for companies to disclose whether their products contain conflict minerals and overturn a Supreme Court ruling allowing courts to defer to regulatory agencies’ interpretations of ambiguous federal laws.
The U.S. launched a trade enforcement action at the World Trade Organization Sept. 13 challenging China’s use of market price support for the production of rice, wheat, and corn. The Obama administration portrayed the case as evidence of its commitment to trade enforcement as part of its ongoing effort to secure congressional approval of the Trans-Pacific Partnership before the end of the year.
The Obama administration’s goals of securing congressional approval of the Trans-Pacific Partnership and concluding negotiations on the Transatlantic Trade and Investment Partnership by the end of 2016 appear to be in jeopardy amid contentious political campaigns and uncertain public opinion trends both in the U.S. and abroad. However, longer term prospects for the two agreements are somewhat brighter.
The Trans-Pacific Partnership could shift global trading patterns for textiles and lower demand for some U.S. textile exports, according to a recent report from the Congressional Research Service.
The tariff classification of many woven apparel products, including recreational performance outerwear as well as a broad range of items that do not fall within the scope of that term, was changed as of Aug. 22. These changes were part of the International Trade Commission’s modification of the Harmonized Tariff Schedule of the United States to implement new tariff classification provisions included in the Trade Facilitation and Trade Enforcement Act of 2015.
U.S. Customs and Border Protection announced Sept. 7 that the mandatory transition of several post-release capabilities to the Automated Commercial Environment has been postponed from Oct. 1 to Oct. 29.
U.S. Customs and Border Protection has set forth the actions to be taken in the following scenarios involving imported cargo being transported by Hanjin Shipping, a major ocean carrier that recently filed for bankruptcy.
U.S. Customs and Border Protection states that it will deploy liquidation capabilities in the Automated Commercial Environment on Oct. 1, at which time liquidations will no longer be processed in the Automated Commercial System and must be done via ACE.
Trade associations are again asking U.S. Customs and Border Protection to delay the deployment of Automated Commercial Environment functionality that they say neither side is ready for. The Trade Leadership Council of the Trade Support Network and the American Association of Exporters and Importers are both concerned about the Oct. 1 deadline for filing drawback and reconciliation entries in ACE.
The Food and Drug Administration has issued a final rule that reorganizes, modifies and clarifies its regulations concerning how and when owners or operators of foreign and domestic establishments at which drugs are manufactured or processed must register their establishments with the FDA and list the drugs they manufacture or process.